Innovid (CTV) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CTV Stock Forecast

Innovid stock forecast is as follows: an average price target of $2.50 (represents a -21.14% downside from CTV’s last price of $3.17) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

CTV Price Target

The average price target for Innovid (CTV) is $2.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $2.50 to $2.50. This represents a potential -21.14% downside from CTV's last price of $3.17.

CTV Analyst Ratings

Buy

According to 4 Wall Street analysts, Innovid's rating consensus is 'Buy'. The analyst rating breakdown for CTV stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Innovid Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jul 23, 2024	Matthew Cost	Morgan Stanley	$2.50	$2.03	23.15%	-21.14%
Apr 16, 2024	Matthew Cost	Morgan Stanley	$2.10	$2.23	-5.83%	-33.75%

The latest Innovid stock forecast, released on Jul 23, 2024 by Matthew Cost from Morgan Stanley, set a price target of $2.50, which represents a 23.15% increase from the stock price at the time of the forecast ($2.03), and a -21.14% decrease from CTV last price ($3.17).

Innovid Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	2
Avg Price Target	-	-	$2.30
Last Closing Price	$3.17	$3.17	$3.17
Upside/Downside	-100.00%	-100.00%	-27.44%

In the current month, the average price target of Innovid stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Innovid's last price of $3.17. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 06, 2024	Needham	Market Outperform	Market Outperform	Hold
Jul 23, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
Jul 12, 2024	Needham	Market Outperform	Market Outperform	Hold
Jun 04, 2024	Needham	Market Outperform	Market Outperform	Hold
Apr 16, 2024	Needham	Market Outperform	Market Outperform	Hold
Apr 16, 2024	Morgan Stanley	Underperform	Underperform	Hold
Apr 16, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
Feb 16, 2024	Wedbush	Outperform	Outperform	Hold
May 11, 2023	Oppenheimer	Outperform	Outperform	Hold
Feb 25, 2022	Needham	Buy	Buy	Hold

Innovid's last stock rating was published by Needham on Aug 06, 2024. The company gave CTV a "Market Outperform" rating, the same as its previous rate.

Innovid Financial Forecast

Innovid Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Revenue	-	-	-	-	-	-	-	-	$38.62M	$36.23M	-	$30.48M	$33.70M	$34.47M	$33.09M	$25.86M	$25.97M
Avg Forecast	$43.85M	$42.65M	$40.75M	$38.95M	$38.80M	$40.80M	$38.50M	$35.15M	$36.20M	$35.47M	$32.00M	$29.53M	$35.47M	$34.47M	$33.50M	$21.27M	$27.05M
High Forecast	$44.47M	$43.25M	$41.33M	$39.50M	$39.35M	$41.38M	$39.04M	$35.65M	$36.71M	$35.47M	$32.45M	$29.95M	$35.97M	$34.47M	$33.50M	$21.27M	$27.05M
Low Forecast	$43.23M	$42.05M	$40.17M	$38.40M	$38.25M	$40.22M	$37.96M	$34.65M	$35.69M	$35.47M	$31.55M	$29.12M	$34.97M	$34.47M	$33.50M	$21.27M	$27.05M
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	1.07%	1.02%	-	1.03%	0.95%	1.00%	0.99%	1.22%	0.96%

Innovid's average Quarter revenue forecast for Mar 24 based on 1 analysts is $35.15M, with a low forecast of $34.65M, and a high forecast of $35.65M. CTV's average Quarter revenue forecast represents a -8.98% decrease compared to the company's last Quarter revenue of $38.62M (Dec 23).

Innovid EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	$1.64M	$5.11M	-	$-6.18M	$-2.08M	$-4.15M	$-8.25M	$-9.12M	$-6.53M
Avg Forecast	$-3.11M	$-3.03M	$-2.89M	$-2.76M	$-2.75M	$-2.90M	$-2.73M	$-2.49M	$-2.57M	$-2.52M	$-2.27M	$-2.10M	$-2.52M	$-2.45M	$-2.38M	$-3.60M	$-334.89M
High Forecast	$-3.07M	$-2.98M	$-2.85M	$-2.73M	$-2.71M	$-2.85M	$-2.69M	$-2.46M	$-2.53M	$-2.52M	$-2.24M	$-2.07M	$-2.48M	$-2.45M	$-2.38M	$-2.88M	$-267.91M
Low Forecast	$-3.16M	$-3.07M	$-2.93M	$-2.80M	$-2.79M	$-2.94M	$-2.77M	$-2.53M	$-2.61M	$-2.52M	$-2.30M	$-2.13M	$-2.55M	$-2.45M	$-2.38M	$-4.32M	$-401.86M
Surprise %	-	-	-	-	-	-	-	-	-0.64%	-2.03%	-	2.95%	0.83%	1.70%	3.47%	2.53%	0.02%

1 analysts predict CTV's average Quarter EBITDA for Mar 24 to be $-2.49M, with a high of $-2.46M and a low of $-2.53M. This is -252.20% lower than Innovid's previous annual EBITDA (Dec 23) of $1.64M.

Innovid Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	$-1.66M	$-2.73M	-	$-8.56M	$-3.43M	$-11.83M	$4.30M	$-7.45M	$-7.62M
Avg Forecast	$4.58M	$1.53M	$-4.58M	$-762.52K	$508.30K	$-508.30K	$-2.03M	$-3.05M	$-1.02M	$-2.03M	$-4.58M	$-7.12M	$-3.05M	$-6.76M	$-5.79M	$-5.96M	$-390.80M
High Forecast	$4.66M	$1.55M	$-4.49M	$-748.52K	$517.63K	$-498.96K	$-2.00M	$-2.99M	$-998.07K	$-2.00M	$-4.49M	$-6.99M	$-2.99M	$-6.76M	$-5.79M	$-4.77M	$-312.64M
Low Forecast	$4.49M	$1.50M	$-4.66M	$-776.52K	$498.96K	$-517.63K	$-2.07M	$-3.11M	$-1.04M	$-2.07M	$-4.66M	$-7.25M	$-3.11M	$-6.76M	$-5.79M	$-7.15M	$-468.96M
Surprise %	-	-	-	-	-	-	-	-	1.63%	1.34%	-	1.20%	1.12%	1.75%	-0.74%	1.25%	0.02%

Innovid's average Quarter net income forecast for Sep 22 is $-6.76M, with a range of $-6.76M to $-6.76M. CTV's average Quarter net income forecast represents a -257.12% decrease compared to the company's last Quarter net income of $4.30M (Jun 22).

Innovid SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	$22.06M	$20.93M	-	$21.29M	$20.56M	$22.77M	$24.27M	$21.99M	$19.61M
Avg Forecast	$27.18M	$26.44M	$25.26M	$24.14M	$24.05M	$25.29M	$23.86M	$21.79M	$22.44M	$21.98M	$19.84M	$18.31M	$21.98M	$21.36M	$20.77M	$17.59M	$16.77M
High Forecast	$27.56M	$26.81M	$25.62M	$24.48M	$24.39M	$25.65M	$24.20M	$22.10M	$22.76M	$21.98M	$20.12M	$18.57M	$22.29M	$21.36M	$20.77M	$21.11M	$16.77M
Low Forecast	$26.80M	$26.06M	$24.90M	$23.80M	$23.71M	$24.93M	$23.53M	$21.48M	$22.12M	$21.98M	$19.56M	$18.05M	$21.67M	$21.36M	$20.77M	$14.07M	$16.77M
Surprise %	-	-	-	-	-	-	-	-	0.98%	0.95%	-	1.16%	0.94%	1.07%	1.17%	1.25%	1.17%

Innovid's average Quarter SG&A projection for Mar 24 is $21.79M, based on 1 Wall Street analysts, with a range of $21.48M to $22.10M. The forecast indicates a -1.22% fall compared to CTV last annual SG&A of $22.06M (Dec 23).

Innovid EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	$-0.01	$-0.02	-	$-0.06	$-0.03	$-0.09	$0.03	$-0.06	$-0.14
Avg Forecast	$0.03	$0.01	$-0.03	$-0.01	-	$-0.00	$-0.01	$-0.02	$-0.01	$-0.01	$-0.03	$-0.05	$-0.02	$-0.05	$-0.04	$-0.05	$-0.01
High Forecast	$0.03	$0.01	$-0.03	$-0.00	-	$-0.00	$-0.01	$-0.02	$-0.01	$-0.01	$-0.03	$-0.05	$-0.02	$-0.05	$-0.04	$-0.05	$-0.01
Low Forecast	$0.03	$0.01	$-0.03	$-0.01	-	$-0.00	$-0.01	$-0.02	$-0.01	$-0.01	$-0.03	$-0.05	$-0.02	$-0.05	$-0.04	$-0.05	$-0.01
Surprise %	-	-	-	-	-	-	-	-	1.77%	1.50%	-	1.35%	1.28%	1.91%	-0.75%	1.20%	10.50%

According to 1 Wall Street analysts, Innovid's projected average Quarter EPS for Sep 22 is $-0.05, with a low estimate of $-0.05 and a high estimate of $-0.05. This represents a -255.56% decrease compared to CTV previous annual EPS of $0.03 (Jun 22).

Innovid Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ADCT	ADC Therapeutics SA	$2.13	$9.33	338.03%	Buy
ADTN	ADTRAN	$8.40	$10.00	19.05%	Buy
BDC	Belden	$118.85	$134.00	12.75%	Buy
CMTL	Comtech Telecommunications	$3.18	$3.50	10.06%	Hold
CTV	Innovid	$3.06	$2.50	-18.30%	Buy

CTV Forecast FAQ

Is Innovid a good buy?

Yes, according to 4 Wall Street analysts, Innovid (CTV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of CTV's total ratings.

What is CTV's price target?

Innovid (CTV) average price target is $2.5 with a range of $2.5 to $2.5, implying a -21.14% from its last price of $3.17. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Innovid stock go up soon?

According to Wall Street analysts' prediction for CTV stock, the company can go down by -21.14% (from the last price of $3.17 to the average price target of $2.5), down by -21.14% based on the highest stock price target, and down by -21.14% based on the lowest stock price target.

Can Innovid stock reach $5?

CTV's average twelve months analyst stock price target of $2.5 does not support the claim that Innovid can reach $5 in the near future.

What are Innovid's analysts' financial forecasts?

Innovid's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $153.25M (high $155.42M, low $151.08M), average EBITDA is $-10.876M (high $-10.722M, low $-11.03M), average net income is $-5.083M (high $-4.971M, low $-5.195M), average SG&A $94.99M (high $96.34M, low $93.65M), and average EPS is $-0.0333 (high $-0.0326, low $-0.0341). CTV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $166.2M (high $168.55M, low $163.85M), average EBITDA is $-11.795M (high $-11.628M, low $-11.962M), average net income is $762.52K (high $972.59K, low $552.45K), average SG&A $103.02M (high $104.48M, low $101.57M), and average EPS is $0.005 (high $0.00638, low $0.00362).

Did the CTV's actual financial results beat the analysts' financial forecasts?

Based on Innovid's last annual report (Dec 2023), the company's revenue was $139.88M, beating the average analysts forecast of $133.2M by 5.02%. Apple's EBITDA was $-5.458M, missing the average prediction of $-9.453M by -42.26%. The company's net income was $-31.911M, beating the average estimation of $-14.742M by 116.46%. Apple's SG&A was $84.66M, beating the average forecast of $82.57M by 2.53%. Lastly, the company's EPS was $-0.23, beating the average prediction of $-0.0967 by 137.93%. In terms of the last quarterly report (Dec 2023), Innovid's revenue was $38.62M, beating the average analysts' forecast of $36.2M by 6.68%. The company's EBITDA was $1.64M, missing the average prediction of $-2.569M by -163.80%. Innovid's net income was $-1.658M, beating the average estimation of $-1.017M by 63.07%. The company's SG&A was $22.06M, missing the average forecast of $22.44M by -1.70%. Lastly, the company's EPS was $-0.0118, beating the average prediction of $-0.00667 by 76.99%